Overview
Li-ming Xu practices in Shijiazhuang, China. Xu is rated as an Experienced expert by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). Their top areas of expertise are Mediastinal Tumor, Squamous Cell Lung Carcinoma, Primary Mediastinal B-Cell Lymphoma (PMBCL), and B-Cell Lymphoma.
Their clinical research consists of co-authoring 28 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Primary Mediastinal B-Cell Lymphoma (PMBCL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Mediastinal TumorXu isAdvanced. Learn about Mediastinal Tumor.
- Experienced
- B-Cell LymphomaXu isExperienced. Learn about B-Cell Lymphoma.
- Breast CancerXu isExperienced. Learn about Breast Cancer.
- Lung CancerXu isExperienced. Learn about Lung Cancer.
- Non-Hodgkin LymphomaXu isExperienced. Learn about Non-Hodgkin Lymphoma.
- Non-Small Cell Lung Cancer (NSCLC)
- Primary Mediastinal B-Cell Lymphoma (PMBCL)